Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01566 |
| Species: | Homo sapiens |
| Position : | chr2:113127450-113127690 |
| Year: | 2025 |
| Title: | Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 40668918 |
| MONDO: | |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | BLaER cells |
| CVCL ID: | CVCL_UI64 |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | WGBS, ATAC-seq, ChIP-seq |
| Low Throughput Method: | CRISPR knockout |
| Target gene : | IL1B |
| TF name : | CEBPA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| CEBPA | AndrogenReceptor | netpath | 167 |
| CEBPA | C-MYB transcription factor network | pid | 87 |
| CEBPA | E2F transcription factor network | pid | 77 |
| CEBPA | EGFR1 | netpath | 475 |
| CEBPA | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| CEBPA | IL4 | netpath | 75 |
| CEBPA | Regulation of Androgen receptor activity | pid | 54 |
| CEBPA | Regulation of retinoblastoma protein | pid | 67 |
| CEBPA | Transcriptional regulation of white adipocyte differentiation | reactome | 79 |
| CEBPA | Validated targets of C-MYC transcriptional repression | pid | 63 |
| CEBPA | Pathways in cancer | kegg | 321 |
| CEBPA | Acute myeloid leukemia | kegg | 53 |
| CEBPA | Hs_Regulation_of_Actin_Cytoskeleton_WP51_79977 | wikipathways | 36 |
| CEBPA | Hs_Pathways_Affected_in_Adenoid_Cystic_Carcinoma_WP3651_89271 | wikipathways | 27 |
| CEBPA | Hs_Nucleotide_Metabolism_WP404_68960 | wikipathways | 16 |
| CEBPA | Hs_Transcription_factor_regulation_in_adipogenesis_WP3599_88581 | wikipathways | 9 |